4th Quarter - Report

HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION for HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Firm
Client
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug and Medical Device (Supply Chain) Safety; DMEPOS Competitive Bidding; Healthcare Reform; Pharmaceutical Pedigree

LobbyistCovered position, as disclosed
AARON FRAZIER Senior Government Affairs Manager
AMY MICHAEL KOHL Senior Government Affairs Manager
ASHLEY PALMER Director, Government Affairs
LINDA ROUSE-O'NEILL Vice President, Government Affairs
MATTHEW JAMES ROWAN President & CEO

Contacted: HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.